ANPI Angiotech Pharmaceuticals - Common Shares (MM)

Angiotech Pharmaceuticals to participate in JP Morgan Healthcare Conference VANCOUVER, Jan. 7 /PRNewswire-FirstCall/ -- Angiotech Pharmaceuticals, Inc. , is scheduled to participate in the 22nd Annual JP Morgan Healthcare Conference hosted by JP Morgan Securities. William Hunter, President and CEO of Angiotech, will be making a 25- minute presentation at the conference on Wednesday, January 14th beginning at 1:00 pm EST (10:00 am PST). A live webcast of Dr. Hunter's remarks will be available to all interested parties at Angiotech's website at http://www.angiotech.com/ in the Investor Relations section. To ensure a timely connection to the webcast, it is recommended that users register at least 15 minutes before the webcast begins. This webcast is being hosted by JP Morgan Securities. The replay will be archived and available in the Investor Relations section of Angiotech's website at http://www.angiotech.com/. Angiotech Pharmaceuticals, Inc. is dedicated to enhancing the performance of medical devices and biomaterials through the innovative use of pharmacotherapeutics. To find out more about Angiotech Pharmaceuticals, Inc. (NASDAQ:ANPINASDAQ:TSX:NASDAQ:ANP), visit our website at http://www.angiotech.com/. Company Contacts: Rui Avelar (analysts), ext 6996 Ian Harper (investors and media), ext 6933 Phone: (604) 221-7676 Web: http://www.angiotech.com/ Email: DATASOURCE: Angiotech Pharmaceuticals, Inc. CONTACT: Rui Avelar (analysts), ext 6996; Ian Harper (investors and media), ext 6933, Phone: 604-221-7676, Web: http://www.angiotech.com/, Email:

Copyright